360:, which all use an explicit process of priority setting. Its findings concluded that all these organizations consider multiple criteria, involved multiple stakeholders, and distinguish, in one way or another, four basic steps in their priority setting Process. These steps were then also applied in the Thai setting and included. The results of the review were adapted to the Thai setting, resulting in 4 steps of explicit priority setting including: 1) nomination of interventions for assessments, 2) selection of interventions for assessment, 3) technology assessment of interventions, and 4) appraisal of interventions. Since the beginning of the research project up to 119 topics have been proposed for inclusion into the benefit package, with 53 topics selected for further research or HTA analysis.
397:
248:
436:. In each of these criteria, the subcommittee’s was to consider scientific evidence to determine which medicines are to be included in the list. Twenty-eight specialist working groups undertake the task of determining what should be on the list as well as informing price negotiations between manufacturers and the NLEM.
477:(UHC) and priority-setting capacity in low- and middle-income countries (LMICs). The HIU has previously worked with the National Center for Pharmaceutical Access and Management (NCPAM), Philippines, Health Technology Assessment Committee (HTAC), Indonesia, Health Systems and Policy Institute (HSPI), Vietnam, the
364:
stakeholders including decision-makers and representatives from the general public, to develop an evidenced-based health screening package for the population that could ensure equitable access to essential health screening under the three schemes. The results led to advice against elements of current
155:
in order to take responsibility for appraising a wide range of health technologies and programs, including pharmaceuticals, medical devices, interventions, individual and community health promotion, and disease prevention as well as social health policy to inform policy decisions in
Thailand. HITAP
459:
schemes and the working group secretariat. In this process, HITAP in collaboration with the Food and Drug
Administration was involved as the secretariat of the working group whose function was to generate procedures and assure quality of the evidence provided. The HEWG then prioritized the requests
300:
The
National Health Security Office, which institutes and manages the largest health plan in Thailand (Universal Coverage Scheme ), initiated a collaborative research and development project with two independent research institutes – the Health Intervention and Technology Assessment Program and the
363:
One of the benefit packages revised through UCBP is the development of a health screening package under the universal health coverage in 2010. Currently, the three public insurance schemes in
Thailand offer different health screening packages. The study was designed as a response to requests from
233:
that are on par with the international level whilst taking into account resource constraints in the Thai context. Under this strategy, methodological guidelines, a database of HTA studies in
Thailand, tools and quality of life measures for cost-utility analysis, and a social value based threshold
507:
HITAP has also worked to establish regional collaboration amongst HTA units in Asia. Along with the
National Evidence-based Health Care Collaborating Agency, South Korea (NECA) and the Center for Drug Evaluation, Taiwan (CDE), HITAP founded the HTAsiaLink Network in 2010. The network is a
209:
In operationalizing HITAP’s goals and in fulfilling its advisory role in the decision making process HITAP follows the five key strategies of having an 1) HTA Fundamental System; 2) strengthening Human
Capacity; 3) HTA Research; 4) Knowledge Management; and 5) creating an HTA Network.
472:
In late 2013 in response to the increasing requests for involvement in international projects, HITAP created the HITAP International Unit in order to collaborate with international partners and networks working to improve health intervention and technology assessment (HITA) for
168:
in support of public decision-making. These assessments cover a range of topics including system design, selection of technologies for assessment, and the actual assessment of those selected and agreed upon by relevant government agencies. In this effort, HITAP publishes
301:
International Health Policy
Program – in 2009. The aim of the project was to develop an optimal strategy for the development of the UC benefit package, that is, to determine which interventions should be candidate for public reimbursement. The project is named
122:
512:
region. One of its many activities is the production of a biannual HTAsialink
Newsletter and an Annual HTAsiaLink Conference held in different member countries in Asia. Currently the Network has 30 member organizations from 16 Countries.
328:(MCDA) and a deliberative process and multi stakeholders’ involvement to guide national-level priority setting in health care coverage decision. The review documented the experience of seven health technology assessment organizations in
265:
388:
B, would provide substantial health and economic benefits to the Thais. The final results were presented to a wide group of stakeholders, including decision-makers at the
Ministry of Public Health and the
488:
In the past HITAP has been instrumental in pushing HTA forward in international policy by becoming part of the delegation representing Thailand as sponsors and writers of several resolutions in the
744:
464:, the risk to life and financial burden on households posed by the condition and social consideration and commissions the cost-effectiveness research from non-profit agencies (like HITAP).
655:
Teerawattananon, Yot; Tritasavit, Nattha; Suchonwanich, N.; Kingkaew, P. (December 2014). "The Use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand".
393:
schemes, to verify and validate the findings and policy recommendations. The package has been endorsed by the Thai UHC Benefit Package Committee for implementation in fiscal year 2016.
749:
201:
measures; benefit packages of care – mixing screening and treatments; and other public health policies, e.g. evaluation of Thailand’s government compulsory license policy.
416:
as its secretariat. In the latter years, the function of the subcommittee became the maintenance of an optimal list of medicines, wherein the criteria for selection were
482:
754:
691:
115:
636:
Tangcharoensathien, V.; Kamolratanakul, P. (2008). "Making sensible rationing: the use of economic evidence and the need for methodological standards".
478:
108:
739:
620:
595:
59:
325:
287:
500:
Health Intervention and Technology Assessment in Support of Universal Health Coverage Agenda. 15.7 A67/VR/9, WHA 67.23 24 May 2014.
269:
413:
85:
40:
439:
Increasingly, awareness and realization that the evidence required for optimal coverage decisions involved analyses in
409:
405:
698:
493:
218:
503:
Health Intervention and Technology Assessment in Support of Universal Health Coverage. SEA/RC66/R4 May, 2014.
390:
258:
152:
489:
474:
304:
178:
226:
157:
317:
440:
230:
194:
190:
447:
Working Group was established under the subcommittee. The working group was composed of health
674:
616:
591:
461:
385:
365:
697:. World Health Organization Regional Office for South-East Asia. 20 July 2015. Archived from
456:
444:
381:
198:
377:
321:
186:
408:
was created. Subsequently, in 1983, the Subcommittee for the Development of the National
692:"Health intervention and technology assessment in support of universal health coverage"
675:"Health Intervention and Technology Assessment in Support of Universal Health Coverage"
452:
222:
733:
429:
341:
509:
548:
156:
assumes an advisory role to health governmental authorities by providing rigorous
345:
247:
161:
508:
collaborative platform for knowledge sharing and best practices of HTA in the
448:
396:
373:
611:
Culyer, Anthony; Podhisita, Chai; Santatiwongchai, Benjarin (January 2016).
584:
Culyer, Anthony; Podhisita, Chai; Santatiwongchai, Benjarin (January 2016).
380:
test), and indicated that the introduction of certain new population-based
615:. Bangkok: Amarin Printing and Publishing Public Co., Ltd. pp. 78–83.
585:
425:
173:
and studies in the following areas: methodological development, (HTA and
170:
148:
144:
349:
333:
272: in this section. Unsourced material may be challenged and removed.
177:) databases and guidelines; knowledge transfer and exchange (KTE) and
657:
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
421:
353:
329:
433:
395:
369:
357:
337:
182:
417:
400:
Thailand National List of Essential Medicines Process Flowchart.
174:
165:
241:
151:’s Ministry of Public Health. It was established in 2007 as a
715:
492:(WHA) and the South-East Asia Regional Office (SEARO) of the
303:
research for development of health benefit package under the
530:
100:
Domestic Public Funding, International Donor Organizations
19:
The Health Intervention and Technology Assessment Program
566:
314:
137:
Health Intervention and Technology Assessment Program
567:"HITAP: โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ"
531:"HITAP: โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ"
96:
81:
66:
54:
46:
36:
28:
23:
18:
745:Medical and health organizations based in Thailand
571:HITAP: โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ
553:HITAP: โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ
535:HITAP: โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ
483:National Institute for Health and Care Excellence
58:6th Floor, 6th Building, Department of Health,
750:Sub-departmental government bodies of Thailand
638:Journal of the Medical Association of Thailand
90:Economic Evaluations, Health Policy Analysis,
116:
8:
613:A Star in the East: A Short History of HITAP
587:A Star in the East: A Short History of HITAP
590:. Bangkok: Amarin Printing and Publishing.
123:
109:
479:International Decision Support Initiative
451:, representatives from the subcommittee,
288:Learn how and when to remove this message
229:and technology assessment by developing
522:
62:, Tiwanon Rd., Muang, Nonthaburi 11000
15:
680:. World Health Assembly. 24 May 2014.
7:
755:Ministry of Public Health (Thailand)
412:who works in collaboration with the
270:adding citations to reliable sources
455:and representatives from the three
443:as a fifth criterion. In 2009, the
326:multiple-criteria decision analysis
14:
246:
740:Research institutes in Thailand
257:needs additional citations for
238:HTA in the public health system
92:HTA Infrastructure Development
1:
404:In 1981, Thailand’s National
70:Yot Teerawattananon MD.PhD.,
414:Food and Drug Administration
324:). The project incorporates
181:; technology assessments on
86:Health Technology Assessment
41:Health Technology Assessment
410:List of Essential Medicines
406:List of Essential Medicines
221:for HTA or the creation of
771:
494:World Health Organization
104:
60:Ministry of Public Health
485:International (NI), UK.
234:ceiling were developed.
219:research and development
24:Overview of Organization
391:public health insurance
368:, such as annual chest
153:non-profit organization
143:) is a semi-autonomous
74:Sripen Tantivess PhD.,
704:on September 19, 2015.
401:
384:programs, such as for
215:HTA fundamental system
490:World Health Assembly
475:Universal Health Care
399:
305:universal health care
160:through professional
266:improve this article
179:capacity development
481:(IDSI), UK and the
227:health intervention
158:scientific evidence
720:www.htasialink.org
496:(WHO), including:
468:International work
441:cost-effectiveness
402:
320:2016-07-09 at the
195:disease prevention
191:medical procedures
622:978-616-11-2820-3
597:978-616-11-2820-3
462:burden of disease
386:chronic hepatitis
366:clinical practice
298:
297:
290:
133:
132:
77:
76:Senior Researcher
73:
762:
724:
723:
712:
706:
705:
703:
696:
688:
682:
681:
679:
671:
665:
664:
652:
646:
645:
640:. Supplement 2.
633:
627:
626:
608:
602:
601:
581:
575:
574:
563:
557:
556:
545:
539:
538:
527:
457:health insurance
445:Health Economics
382:health screening
293:
286:
282:
279:
273:
250:
242:
199:health promotion
125:
118:
111:
75:
71:
16:
770:
769:
765:
764:
763:
761:
760:
759:
730:
729:
728:
727:
714:
713:
709:
701:
694:
690:
689:
685:
677:
673:
672:
668:
654:
653:
649:
635:
634:
630:
623:
610:
609:
605:
598:
583:
582:
578:
565:
564:
560:
547:
546:
542:
529:
528:
524:
519:
470:
378:kidney function
372:and particular
322:Wayback Machine
307:coverage scheme
294:
283:
277:
274:
263:
251:
240:
207:
187:medical devices
129:
97:Funding Sources
12:
11:
5:
768:
766:
758:
757:
752:
747:
742:
732:
731:
726:
725:
707:
683:
666:
647:
628:
621:
603:
596:
576:
558:
540:
521:
520:
518:
515:
505:
504:
501:
469:
466:
309:, or known as
296:
295:
254:
252:
245:
239:
236:
223:infrastructure
217:entails basic
206:
203:
131:
130:
128:
127:
120:
113:
105:
102:
101:
98:
94:
93:
83:
82:Research Areas
79:
78:
72:Program Leader
68:
64:
63:
56:
52:
51:
48:
44:
43:
38:
34:
33:
30:
26:
25:
21:
20:
13:
10:
9:
6:
4:
3:
2:
767:
756:
753:
751:
748:
746:
743:
741:
738:
737:
735:
721:
717:
711:
708:
700:
693:
687:
684:
676:
670:
667:
663:(7): 397–404.
662:
658:
651:
648:
643:
639:
632:
629:
624:
618:
614:
607:
604:
599:
593:
589:
588:
580:
577:
572:
568:
562:
559:
554:
550:
544:
541:
536:
532:
526:
523:
516:
514:
511:
502:
499:
498:
497:
495:
491:
486:
484:
480:
476:
467:
465:
463:
458:
454:
450:
446:
442:
437:
435:
431:
430:effectiveness
427:
423:
419:
415:
411:
407:
398:
394:
392:
387:
383:
379:
375:
371:
367:
361:
359:
355:
351:
347:
343:
342:United States
339:
335:
331:
327:
323:
319:
316:
312:
308:
306:
292:
289:
281:
271:
267:
261:
260:
255:This section
253:
249:
244:
243:
237:
235:
232:
228:
224:
220:
216:
211:
204:
202:
200:
196:
192:
188:
184:
180:
176:
172:
167:
163:
159:
154:
150:
146:
142:
138:
126:
121:
119:
114:
112:
107:
106:
103:
99:
95:
91:
87:
84:
80:
69:
67:Key Personnel
65:
61:
57:
53:
49:
45:
42:
39:
37:Field of Work
35:
31:
27:
22:
17:
719:
716:"HTAsiaLink"
710:
699:the original
686:
669:
660:
656:
650:
641:
637:
631:
612:
606:
586:
579:
570:
561:
552:
549:"Contact Us"
543:
534:
525:
510:Asia-Pacific
506:
487:
471:
438:
403:
362:
315:www.ucbp.net
310:
302:
299:
284:
275:
264:Please help
259:verification
256:
214:
212:
208:
140:
136:
134:
89:
55:Headquarters
346:Netherlands
225:to support
147:unit under
734:Categories
644:: S88–S99.
517:References
449:economists
374:blood test
213:Having an
205:Strategies
164:of health
162:assessment
460:based on
453:academics
278:July 2016
231:standards
426:efficacy
318:Archived
171:research
149:Thailand
145:research
32:Research
350:Germany
334:England
47:Founded
619:
594:
422:safety
376:(e.g.
370:X-rays
354:Sweden
344:, the
340:, the
330:Canada
702:(PDF)
695:(PDF)
678:(PDF)
434:drugs
358:Spain
338:Wales
313:(see
183:drugs
141:HITAP
617:ISBN
592:ISBN
428:and
418:cost
356:and
336:and
311:UCBP
197:and
175:cost
166:data
135:The
50:2007
29:Type
661:108
432:of
268:by
736::
718:.
659:.
642:91
569:.
551:.
533:.
424:,
420:,
352:,
348:,
332:,
193:,
189:,
185:,
88:,
722:.
625:.
600:.
573:.
555:.
537:.
291:)
285:(
280:)
276:(
262:.
139:(
124:e
117:t
110:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
